Aclaris Therapeutics (ACRS) Gross Margin Growth (3y) (2020 - 2026)
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 569.00 |
| 10 | Aclaris Therapeutics | 877.12 Mn | 877.12 Mn | 1.41 Mn | 4,237.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,237.00 |
| Mar 31, 2026 | 1,217.00 |
| Dec 31, 2025 | -2,977.00 |
| Sep 30, 2025 | -1,145.00 |
| Jun 30, 2025 | 4,091.00 |
| Mar 31, 2025 | 4,471.00 |
| Dec 31, 2024 | 6,890.00 |
| Sep 30, 2024 | 5,120.00 |
| Jun 30, 2024 | 4,668.00 |
| Mar 31, 2024 | 3,391.00 |
| Dec 31, 2023 | 7,727.00 |
| Sep 30, 2023 | 7,292.00 |
| Jun 30, 2023 | 1,214.00 |
| Mar 31, 2023 | 5,823.00 |
| Dec 31, 2022 | 8,248.00 |
| Sep 30, 2022 | 7,918.00 |
| Jun 30, 2022 | 4,229.00 |
| Mar 31, 2022 | 1,608.00 |
| Dec 31, 2021 | 1,909.00 |
| Sep 30, 2021 | -515.00 |